Innovative Roche cancer medicine Avastin approved in EU

First treatment of its kind with proven survival benefit for patients with advanced colorectal cancer - Roche today announced that the European Commission has approved Avastin (bevacizumab, rhuMAb-VEGF), the new innovative anti-angiogenesis drug for the treatment of patients with previously untreated metastatic colorectal cancer... click ...

Continue to Innovative Roche cancer medicine Avastin approved in EU on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz